TomoTherapy Incorporated and its subsidiaries develop, manufacture, market, and sell radiation therapy solutions to treat a range of cancer types. Its TomoTherapy treatment systems include the Hi Art treatment system, which delivers CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD treatment system that includes TomoHelical and TomoDirect treatment modalities to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile treatment system, which is a relocatable radiation therapy solution. The company markets and sells its products to hospitals and cancer treatment centers in North America, Europe, the Middle East, and the Asia-Pacific. It sells markets and sells its products through direct sales personnel, third-party distributors, and third-party sales agents or distributors. The company was founded in 1997 and is headquartered in Madison, Wisconsin.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for TOMO